TY  - JOUR
T1  - Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: Current practice
AU  - Shah B, Danoff A, Radford MJ, Rolnitzky L, Sedlis SP
Y1  - 2012/10/22
N1  - 10.1001/archinternmed.2012.3630
JO  - Archives of Internal Medicine
SP  - 1514
EP  - 1516
VL  - 172
IS  - 19
N2  - 
Despite advances in procedural technique and pharmacotherapy, patients with diabetes mellitus (DM) experience worse outcomes than patients without DM undergoing percutaneous coronary intervention (PCI).1 Periprocedural hyperglycemia is associated with adverse clinical outcomes in patients undergoing PCI,2- 5 and studies have suggested that treating periprocedural hyperglycemia may improve outcomes by attenuating glucose-mediated ischemic injury at the time of PCI.6- 7 Simple preventive strategies, such as continuing long-acting hypoglycemic medications, have not been evaluated, and there are no guidelines for periprocedural use of these medications.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.3630
UR  - http://dx.doi.org/10.1001/archinternmed.2012.3630
ER  -